HLA-corrected tumor mutation burden and homologous recombination de fi ciency for the prediction of response to PD -(L)1 blockade in advanced non -small -cell lung cancer patients

ANNALS OF ONCOLOGY

ELSEVIER

1. Post-Genome Technology Development Program (Business model development driven by the clinico-genomic database for precision immuno-oncology) - Ministry of Trade, Industry and Energy (MOTIE, Korea) [10067758]
2. National Research Foundation of Korea - Korean Government (NRF-2018-Global PhD Fellowship Program) [2018H1A2A1062330]
3. US National Institutes of Health [CA121113]
4. Eastern Cooperative Oncology Group-American College of Radiology Imaging Network
5. V Foundation
6. Swim Across America
7. Allegheny Health Networkd-Johns Hopkins Research Fund
8. LUNGevity Foundation
9. National Research Foundation of Korea [2018H1A2A1062330] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)